GO
Loading...

FDA

More

  • Dendreon TV Thursday, 10 May 2007 | 11:35 AM ET

    While I'm watching the webcast of the FDA Advisory Committee Meeting on the anemia drugs (Amgen, Johnson & Johnson), I wanted to hop on my TV versus print soapbox one more time.As I posted yesterday, I had asked a Dendreon spokeswoman for an interview with CEO Dr. Mitchell Gold in the wake of the FDA sending the company an "approvable letter" for its prostate cancer treatment Provenge.

  • Shares of Biotech drug maker Dendreon sank more than 50% after the FDA requested more clinical data on the effectiveness of its prostate cancer treatment, Provenge, delaying the drug's approval.

  • Alli: Buy the Book Wednesday, 2 May 2007 | 11:47 AM ET

    GlaxoSmithKline's Alli (pronounced "ally" -- don't ask me why they put an "i" at the end) is the new over-the-counter version of prescription Xenical from Roche. It's a diet pill, but as I previously blogged, it has potentially embarrassing side effects. On the plus side, GSK says you can subtract 50% more pounds if you use Alli as directed. But, if you still eat too many fatty foods, you could run into trouble.

  • Glaxo Wins FDA Approval for Allergy Spray Friday, 27 Apr 2007 | 5:44 PM ET

    Analysts have projected peak sales of up to $1 billion a year for the allergy treatment, which is chemically known as fluticasone furoate.

  • Merck's Vioxx Successor Rejected by FDA Friday, 27 Apr 2007 | 4:12 PM ET

    The decision was widely expected, after a panel of FDA advisers two weeks ago voted 20-1 against approving the drug, Arcoxia.

  • Depressed Pooch? Eli Lilly Gets FDA Approval for New Drug Wednesday, 25 Apr 2007 | 11:19 AM ET

    Eli Lilly  announced Wednesday it has received approval from the FDA to market Reconcile, the first selective serotonin reuptake inhibitor (SSRI) class of antidepressants approved by the FDA for treatment of canine separation anxiety in conjunction with behavior modification training.

  • Mylan Laboratories spacer said U.S. regulators approved its generic version of Sanofi-Aventis' sleeping pill, Ambien, in the 5 mg and 10 mg strengths.

  • First Bird Flu Vaccine Wins FDA Approval Tuesday, 17 Apr 2007 | 2:36 PM ET

    A bird flu vaccine made by Sanofi Aventis is the first to gets federal approval as a stopgap measure against a potential pandemic until more effective vaccines can be developed.

  • Boston Scientific Says Plant Problems Resolved Monday, 16 Apr 2007 | 10:55 AM ET

    Boston Scientific said on Monday it had resolved deficiencies that U.S. regulators had found at a plant that manufactures heart rhythm devices, sending its shares up nearly 7%.

  • Merck's new pain reliever drug Arcoxia, which was proposed as a successor to Vioxx, was rejected by a federal health advisory panel. A Food and Drug Administration drug safety expert earlier told the panel that the drug may increase substantially the risk of stroke and heart attack and is no more effective for pain relief than other medicines in the same class.

  • An analyst sounded a warning note on shares of biotechnology company Dendreon on Monday, which have more than tripled in value since March 30, but the stock continued to rise.

  • Fresh fish is displayed at a New York market.

    The Food and Drug Administration doesn’t have the staff to inspect all food imported to the U.S., raising basic health concerns and forcing consumers to take producers' word that it’s safe, a food expert said.

  • Shares of Dendreon shot up after a panel of FDA advisers voted Provenge is both safe and effective in treating advanced prostate cancer.

  • Shares of Dendreon are up about 250% in pre-market trading after a panel of FDA advisers voted Provenge is both safe and effective in treating advanced prostate cancer.

  • Dendreon Shares Take Off Ahead of FDA Panel Meeting Wednesday, 28 Mar 2007 | 4:07 PM ET

    Shares of pharmaceutical firm Dendreon leaped on Wednesday following a CNBC report about a planned Thursday Food and Drug Administration hearing that could determine the fate of a prostate cancer drug from the company.

  • The Southern California farm that grew the green onions that were first linked to and then cleared in last year's E. coli outbreak has filed a libel lawsuit against Taco Bell. 

  • Cepheid Meningitis Drug Gets Approval from FDA Friday, 16 Mar 2007 | 1:14 PM ET

    The test, called the Xpert EV test, can detect the condition in 2.5 hours compared with other products that can take as long as a week, the FDA said.

  • U.S. health regulators have approved GlaxoSmithKline's pill Tykerb for patients with advanced breast cancer after other treatments have failed, a company spokeswoman said on Tuesday.

  • J.P. Garnier, GlaxoSmithKline's chief executive officer, told CNBC's "Squawk Box" Wednesday that he expects to make the company's new drug for advanced breast cancer available to U.S. patients "within a few days."

  • Three Amgen Drugs to Carry New FDA Warning Friday, 9 Mar 2007 | 3:30 PM ET

    The U.S. Food and Drug Administration on Friday issued a public health advisory for three widely-used drugs manufactured by Amgen for the treatment of anemia.